Navigation Links
Global Specialty Enzymes Industry
Date:3/16/2011

NEW YORK, March 16, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Specialty Enzymes Industry

http://www.reportlinker.com/p090599/Global-Specialty-Enzymes-Industry.html

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 44 companies including many key and niche players such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories Limited, Danisco A/S, Genencor International, Inc., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SPECIALTY ENZYMES MCP-2056

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability And Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions And Scope Of Study 3

Specialty Medical Enzymes 4

Polymerases 4

Nucleases 4

Other Specialty Enzymes 4

Pharmaceuticals/Diagnostic 4

Research/Biotechnology 4

2. GLOBAL MARKET OVERVIEW 5

Current and Future Analysis 5

Recession Derails the Market Momentum 6

Competitive Scenario 6

Table 1: Leading Players in the Global Enzyme Market (2009):

Percentage Breakdown of Value Sales for Novozymes, Danisco,

Genzyme, Roche, Allergan, DSM and Others (includes

corresponding Graph/Chart) 6

3. ENZYMES - A REVIEW 7

Definition 7

Introduction 7

Advantages of Enzymes Compared to Chemical Catalysts 8

A Brief History 8

4. SPECIALTY ENZYMES: AN OVERVIEW 9

Analysis of Product Segments 9

Specialty Medical Enzymes 9

Polymerases 10

Nucleases 10

Other Specialty Enzymes 10

5. ANALYSIS OF THE END-USE MARKETS 11

Pharmaceuticals & Diagnostics 11

Research/Biotechnology 11

Other End Use Markets 11

6. TECHNOLOGY TRENDS 12

Protein Engineering Technology 12

Specialty Enzymes in Industrial Uses 12

Enzyme Technology in Pig Industry 13

7. PRODUCT INTRODUCTIONS/INNOVATIONS 14

Verenium Launches Xylathin 14

Novagen Introduces Novagen® KOD XtremeTM Hot Start DNA

Polymerase Kit 14

Verenium Launches New Veretase High-Performance Enzyme 14

8. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST -

A PERSPECTIVE BUILDER 16

MARDI Develops Taq DNA Polymerase 16

Stratagene Corporation Commercializes DNA Polymerases 16

Takara Bio Launches PrimeSTAR HS DNA Polymerase 16

9. RECENT INDUSTRY ACTIVITY 17

Thermo Fisher Scientific Acquires Finnzymes 17

Verenium and Add Food Service Enter into an Agreement 17

Verenium and Syngenta End Collaborative Research Program 17

Verenium Collaborates with Alfa Laval for Purifine PLC Enzyme 18

Verenium and Bunge Enter into an Agreement for Enzyme Process

Development 18

Inverness Medical Innovations Acquires BBI Holdings Plc 19

Helix Biopharma Enters into a Contract with KBI Biopharma 19

Verenium Enters into Agreement with Bunge Oils 19

10. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 20

BBI Holdings Acquires Theratase Plc 20

Danisco to Acquire Stake in South African Firm 20

Affymetrix to Buy USB Corporation 20

Diversa Merges with Celunol to Form Verenium Corporation 20

Diversa Collaborates with BASF 20

Codexis Expands Collaboration with Royal Dutch Shell to

Develop Super Enzymes 21

Diversa Enters into a Deal with Syngenta to Develop Enzymes 21

Genencor Begins Operation at New China Site and Introduces a

New Detergent Enzyme 21

Verenium Receives $4.6 million For Enzyme Development 21

Biocon Divests its Enzymes Business to Novozymes 21

Solexa Signs Agreement with New England Biolabs 22

Danisco Takes Over Genencor 22

IBEX Technologies Inks Agreement with Cape Cod and Prozyme 22

11. FOCUS ON SELECT GLOBAL PLAYERS 23

Advanced Enzymes Technologies Limited (India) 23

Amano Enzyme, Inc. (Japan) 23

Aureozyme, Inc. (US) 23

Biocon Ltd. (India) 24

Biozyme Laboratories Limited (UK) 24

Danisco A/S (Denmark) 25

Genencor International, Inc. (US) 25

Kinetic Biosystems, Inc. (US) 26

Maxygen, Inc. (US) 26

Codexis Inc. (US) 26

Novozymes A/S (Denmark) 26

Seravac Biotech (Pty) Ltd. (South Africa) 27

Specialty Enzymes & Biotechnologies Co. (US) 27

Verenium Corporation (US) 27

12. GLOBAL MARKET PERSPECTIVE 28

Table 2: World Recent Past, Current & Future Analysis for

Specialty Enzymes by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and Latin

America Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 28

Table 3: World Historic Review for Specialty Enzymes by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 29

Table 4: World 11-Year Perspective for Specialty Enzymes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 30

Table 5: World Recent Past, Current & Future Analysis for

Specialty Medical Enzymes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 31

Table 6: World Historic Review for Specialty Medical Enzymes

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 32

Table 7: World 11-Year Perspective for Specialty Medical

Enzymes by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 33

Table 8: World Recent Past, Current & Future Analysis for

Polymerases by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 34

Table 9: World Historic Review for Polymerases by Geographic

Region - US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 35

Table 10: World 11-Year Perspective for Polymerases by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 36

Table 11: World Recent Past, Current & Future Analysis for

Nucleases by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 37

Table 12: World Historic Review for Nucleases by Geographic

Region - US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 38

Table 13: World 11-Year Perspective for Nucleases by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 39

Table 14: World Recent Past, Current & Future Analysis for

Other Specialty Enzymes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 40

Table 15: World Historic Review for Other Specialty Enzymes by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 41

Table 16: World 11-Year Perspective for Other Specialty

Enzymes by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 42

Table 17: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics

by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 43

Table 18: World Historic Review for Specialty Enzymes

Consumption in Pharmaceuticals & Diagnostics by Geographic

Region- US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 44

Table 19: World 11-Year Perspective for Specialty Enzymes

Consumption in Pharmaceuticals & Diagnostics by Geographic

Region - Percentage Breakdown of Dollar Sales for US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets for Years 2005, 2010 & 2015

(includes corresponding Graph/Chart) 45

Table 20: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Research/Biotechnology by

Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 46

Table 21: World Historic Review for Specialty Enzymes

Consumption in Research/Biotechnology by Geographic Region-

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 47

Table 22: World 11-Year Perspective for Specialty Enzymes

Consumption in Research/Biotechnology by Geographic Region -

Percentage Breakdown of Dollar Sales for US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and Latin

America Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 48

Table 23: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Other End-Use Segments by

Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 49

Table 24: World Historic Review for Specialty Enzymes

Consumption in Other End-Use Segments by Geographic Region-

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 50

Table 25: World 11-Year Perspective for Specialty Enzymes

Consumption in Other End-Use Segments by Geographic Region -

Percentage Breakdown of Dollar Sales for US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and Latin

America Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 51

13. THE UNITED STATES 52

A.Market Analysis 52

Current and Future Analysis 52

Competitive Scenario 52

Table 26: Leading Players in the US Enzyme Market (2008):

Percentage Breakdown of Value Sales for Novozymes, Danisco,

Allergan, Genzyme, Genentech, and Others (includes

corresponding Graph/Chart) 52

Market Dynamics 53

Specialty Enzymes Market is Projected to Rise 53

Specialty Enzymes Form the Leading Enzymes Segment 53

Pharmaceuticals and Diagnostics Continue to be the Largest

Market 53

Specialty Medical Enzymes in a Myriad of Novel Applications 53

Market for Enzymes in Biotechnology 53

B.Market Analytics 54

Table 27: US Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 54

Table 28: US Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 55

Table 29: US 11-Year Perspective for Specialty Enzymes by

Product Segment - Percentage Breakdown of Dollar Sales for

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 56

Table 30: US Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 57

Table 31: US Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 58

Table 32: US 11-Year Perspective for Specialty Enzymes by

End-Use Segment - Percentage Breakdown of Dollar Sales for

Pharmaceuticals & Diagnostics, Research/Biotechnology and

Others Markets for 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 58

14. CANADA 59

Market Analysis 59

Table 33: Canadian Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015(includes corresponding

Graph/Chart) 59

Table 34: Canadian Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 60

Table 35: Canadian 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 61

Table 36: Canadian Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research / Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 62

Table 37: Canadian Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 63

Table 38: Canadian 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 63

15. JAPAN 64

Market Analysis 64

Table 39: Japanese Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 64

Table 40: Japanese Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 65

Table 41: Japanese 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 66

Table 42: Japanese Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 67

Table 43: Japanese Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 68

Table 44: Japanese 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research / Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 68

16. EUROPE 69

Market Analysis 69

Table 45: European Recent Past, Current & Future Analysis

for Specialty Enzymes by Geographic Region - France,

Germany, Italy, UK, Spain, Russia, and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 70

Table 46: European Historic Review for Specialty Enzymes by

Geographic Region - France, Germany, Italy, UK, Spain,

Russia, and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 71

Table 47: European 11-Year Perspective for Specialty Enzymes

by Geographic Region - Percentage Breakdown of Dollar Sales

for France, Germany, Italy, UK, Spain, Russia, and Rest of

Europe Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 72

Table 48: European Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 73

Table 49: European Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 74

Table 50: European 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 75

Table 51: European Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 76

Table 52: European Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 77

Table 53: European 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 78

16a. FRANCE 79

Market Analysis 79

Table 54: French Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 79

Table 55: French Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 80

Table 56: French 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 81

Table 57: French Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/ Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 82

Table 58: French Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 83

Table 59: French 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 83

16b. GERMANY 84

Market Analysis 84

Table 60: German Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 84

Table 61: German Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 85

Table 62: German 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 86

Table 63: German Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 87

Table 64: German Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 88

Table 65: German 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 88

16c. ITALY 89

Market Analysis 89

Table 66: Italian Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 89

Table 67: Italian Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 90

Table 68: Italian 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 91

Table 69: Italian Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 92

Table 70: Italian Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology, and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 93

Table 71: Italian 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 93

16d. THE UNITED KINGDOM 94

Market Analysis 94

Table 72: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 94

Table 73: UK Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 95

Table 74: UK 11-Year Perspective for Specialty Enzymes by

Product Segment - Percentage Breakdown of Dollar Sales for

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 96

Table 75: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 97

Table 76: UK Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2000 through

2006 (includes corresponding Graph/Chart) 98

Table 77: UK 11-Year Perspective for Specialty Enzymes by

End-Use Segment - Percentage Breakdown of Dollar Sales for

Pharmaceuticals & Diagnostics, Research/ Biotechnology and

Others Markets for2005, 2010 & 2015 (includes corresponding

Graph/Chart) 98

16e. SPAIN 99

Market Analysis 99

Table 78: Spanish Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 99

Table 79: Spanish Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 100

Table 80: Spanish 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015(includes

corresponding Graph/Chart) 101

Table 81: Spanish Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015(includes corresponding

Graph/Chart) 102

Table 82: Spanish Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 103

Table 83: Spanish 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 103

16f. RUSSIA 104

Market Analysis 104

Table 84: Russian Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 104

Table 85: Russian Historic Review for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 105

Table 86: Russian 11-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 106

Table 87: Russian Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 107

Table 88: Russian Historic Review for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 108

Table 89: Russian 11-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research / Biotechnology

and Others Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 108

16g. REST OF EUROPE 109

Market Analysis 109

Table 90: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 109

Table 91: Rest of Europe Historic Review for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 110

Table 92: Rest of Europe 11-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 111

Table 93: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research / Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 112

Table 94: Rest of Europe Historic Review for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research / Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 113

Table 95: Rest of Europe 11-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 114

17. ASIA-PACIFIC 115

A.Market Analysis 115

Current and Future Analysis 115

Enzyme Market in China 115

Enzyme Demand by End-Use 115

Table 96: Chinese Enzyme Market (2009): Percentage

Breakdown of Dollar Demand by End-Use Market - Industrial

(Food & Beverage, Cleaning Products, Animal Feed, Ethanol

Production, and Other Industrial) and Specialty (includes

corresponding Graph/Chart) 116

Enzyme Demand by Enzyme Type 116

Table 97: Chinese Enzyme Market (2009): Percentage

Breakdown of Dollar Demand by Enzyme Type - Carbohydrases

(Amylases and Other Carbohydrases), Proteases, Lipases,

Polymerases & Nucleases, and Other Enzymes (includes

corresponding Graph/Chart) 116

B.Market Analytics 117

Table 98: Asia-Pacific Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 117

Table 99: Asia-Pacific Historic Review for Specialty Enzymes

by Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 118

Table 100: Asia-Pacific 11-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 119

Table 101: Asia-Pacific Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research / Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 120

Table 102: Asia-Pacific Historic Review for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research / Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 121

Table 103: Asia-Pacific 11-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 122

18. THE MIDDLE EAST 123

Market Analysis 123

Table 104: Middle East Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 123

Table 105: Middle East Historic Review for Specialty Enzymes

by Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 124

Table 106: Middle East 11-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 125

Table 107: Middle East Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research/Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 126

Table 108: Middle East Historic Review for Specialty Enzymes

by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 127

Table 109: Middle East 11-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 128

19. LATIN AMERICA 129

Market Analysis 129

Table 110: Latin American Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 129

Table 111: Latin American Historic Review for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 130

Table 112: Latin American 11-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 131

Table 113: Latin American Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research/ Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 132

Table 114: Latin American Historic Review for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 133

Table 115: Latin American 11-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 134

COMPETITION

Total Companies Profiled: 44 (including Divisions/Subsidiaries - 46)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 25

Canada 3

Japan 2

Europe 11

Germany 1

The United Kingdom 2

Rest of Europe 8

Asia-Pacific (Excluding Japan) 4

Africa 1

------------------------------------------

To order this report:Biotechnology Industry: Global Specialty Enzymes Industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
2. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
3. Forward step in forecasting global warming
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
10. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
11. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads ... on the secure online PatientCrossroads platform, has exceeded both its one-year and overall ... the PROMPT study, which seeks to advance understanding of the hereditary risks for ...
(Date:2/10/2016)... ... ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on the discovery and ... been selected to present at the Cavendish Global Health Impact Forum taking place February ... of the Forum is to help family offices and foundations develop and implement their ...
(Date:2/9/2016)... N.J. , Feb. 9, 2016  Regenicin, ... biotechnology company specializing in the development and commercialization ... of damaged tissues and organs, recently reported the ... the first quarter of 2016. Lonza ... the new 2015 fiscal year in the process ...
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo , the ... validated Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) ... 2016 Conference in San Mateo, California on February 10th and 11th. Watch ...
Breaking Biology Technology:
(Date:1/27/2016)... WEST CHESTER, Ohio , Jan. 27, 2016 /PRNewswire/ ... services supplier based in West Chester, Ohio ... and their award winning service staff, based in ... Track,s technical capacity and ability to provide modifications, installations ... John Dovalina , CEO of PLUS, commented, "PLUS ...
(Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):